Journal Article DZNE-2021-01138

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Effect of the COVID-19 lockdown on disease recognition and utilisation of healthcare services in the older population in Germany: a cross-sectional study.

 ;  ;  ;

2021
Oxford Univ. Press Oxford

Age & ageing 50(2), 317 - 325 () [10.1093/ageing/afaa260]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: There is little evidence about the utilisation of healthcare services and disease recognition in the older population, which was urged to self-isolate during the COVID-19 lockdown.We aimed to describe the utilisation of physician consultations, specialist referrals, hospital admissions and the recognition of incident diseases in Germany for this age group during the COVID-19 lockdown.Cross-sectional observational study.1,095 general practitioners (GPs) and 960 specialist practices in Germany.2.45 million older patients aged 65 or older.The number of documented physician consultations, specialist referrals, hospital admissions and incident diagnoses during the imposed lockdown in 2020 was descriptively analysed and compared to 2019.Physician consultations decrease slightly in February (-2%), increase before the imposed lockdown in March (+9%) and decline in April (-18%) and May (-14%) 2020 compared to the same periods in 2019. Volumes of hospital admissions decrease earlier and more intensely than physician consultations (-39 versus -6%, respectively). Overall, 15, 16 and 18% fewer incident diagnoses were documented by GPs, neurologists and diabetologists, respectively, in 2020. Diabetes, dementia, depression, cancer and stroke were diagnosed less frequently during the lockdown (-17 to -26%), meaning that the decrease in the recognition of diseases was greater than the decrease in physician consultations.The data suggest that organisational changes were adopted quickly by practice management but also raise concerns about the maintenance of routine care. Prospective studies should evaluate the long-term effects of lockdowns on patient-related outcomes.

Keyword(s): Aged (MeSH) ; COVID-19: diagnosis (MeSH) ; COVID-19: epidemiology (MeSH) ; COVID-19: prevention & control (MeSH) ; COVID-19: therapy (MeSH) ; Communicable Disease Control: organization & administration (MeSH) ; Cross-Sectional Studies (MeSH) ; Delayed Diagnosis: adverse effects (MeSH) ; Delayed Diagnosis: statistics & numerical data (MeSH) ; Delivery of Health Care: methods (MeSH) ; Delivery of Health Care: organization & administration (MeSH) ; Female (MeSH) ; Germany: epidemiology (MeSH) ; Humans (MeSH) ; Male (MeSH) ; Noncommunicable Diseases: epidemiology (MeSH) ; Noncommunicable Diseases: therapy (MeSH) ; Organizational Innovation (MeSH) ; Patient Acceptance of Health Care: statistics & numerical data (MeSH) ; Quarantine: methods (MeSH) ; SARS-CoV-2 (MeSH) ; COVID-19 ; healthcare utilisation ; lockdown ; older people ; recognition

Classification:

Contributing Institute(s):
  1. Translational Health Care Research (AG Hoffmann)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2021
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > ROS DZNE > ROS DZNE-AG Hoffmann
Public records
Publications Database

 Record created 2021-09-20, last modified 2024-03-05


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)